APR003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APR003, covering 2025-08-06 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions [Phase 1]